Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells

Weining Zhen, Hiremagalur N. Jayaram, Victor E. Marquez, Barry M. Goldstein, David A. Cooney, George Weber

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

2-β-D-Arabinofuranosylthiazole-4-carboxamide and 2-β-D-xylofuranosyl-thiazole-4-carboxamide are sugar modified analogues of tiazofurin, a C-glycosyl nucleoside which after anabolism to the dinucleotide, TAD (thiazole-4-carboxamide adenine dinucleotide), exhibits antitumor activity. However, ara-T and xylo-T did not exhibit cytotoxicity. Compared to tiazofurin, only 12.5% of the ara-T and 8.8% of the xylo-T were metabolized to TAD derivatives by human myelogenous leukemia K562 cells. This was reflected in the finding that guanylate pools were not depressed after treatment with either tiazofurin derivative. These results provide evidence that the ribose moiety is essential for the metabolism and cytotoxicity of tiazofurin. This investigation should be helpful in the design of new analogues of tiazofurin for future clinical trials.

Original languageEnglish
Pages (from-to)933-938
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume180
Issue number2
DOIs
StatePublished - Oct 31 1991

Fingerprint

tiazofurin
Arabinose
K562 Cells
Xylose
Cytotoxicity
Derivatives
Thiazoles
Myeloid Leukemia
Ribose
Nucleosides
Metabolism
Sugars
Clinical Trials

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells. / Zhen, Weining; Jayaram, Hiremagalur N.; Marquez, Victor E.; Goldstein, Barry M.; Cooney, David A.; Weber, George.

In: Biochemical and Biophysical Research Communications, Vol. 180, No. 2, 31.10.1991, p. 933-938.

Research output: Contribution to journalArticle

Zhen, Weining ; Jayaram, Hiremagalur N. ; Marquez, Victor E. ; Goldstein, Barry M. ; Cooney, David A. ; Weber, George. / Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells. In: Biochemical and Biophysical Research Communications. 1991 ; Vol. 180, No. 2. pp. 933-938.
@article{4e22cbb6b109434e84eeee9ca32fb39f,
title = "Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells",
abstract = "2-β-D-Arabinofuranosylthiazole-4-carboxamide and 2-β-D-xylofuranosyl-thiazole-4-carboxamide are sugar modified analogues of tiazofurin, a C-glycosyl nucleoside which after anabolism to the dinucleotide, TAD (thiazole-4-carboxamide adenine dinucleotide), exhibits antitumor activity. However, ara-T and xylo-T did not exhibit cytotoxicity. Compared to tiazofurin, only 12.5{\%} of the ara-T and 8.8{\%} of the xylo-T were metabolized to TAD derivatives by human myelogenous leukemia K562 cells. This was reflected in the finding that guanylate pools were not depressed after treatment with either tiazofurin derivative. These results provide evidence that the ribose moiety is essential for the metabolism and cytotoxicity of tiazofurin. This investigation should be helpful in the design of new analogues of tiazofurin for future clinical trials.",
author = "Weining Zhen and Jayaram, {Hiremagalur N.} and Marquez, {Victor E.} and Goldstein, {Barry M.} and Cooney, {David A.} and George Weber",
year = "1991",
month = "10",
day = "31",
doi = "10.1016/S0006-291X(05)81155-6",
language = "English",
volume = "180",
pages = "933--938",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells

AU - Zhen, Weining

AU - Jayaram, Hiremagalur N.

AU - Marquez, Victor E.

AU - Goldstein, Barry M.

AU - Cooney, David A.

AU - Weber, George

PY - 1991/10/31

Y1 - 1991/10/31

N2 - 2-β-D-Arabinofuranosylthiazole-4-carboxamide and 2-β-D-xylofuranosyl-thiazole-4-carboxamide are sugar modified analogues of tiazofurin, a C-glycosyl nucleoside which after anabolism to the dinucleotide, TAD (thiazole-4-carboxamide adenine dinucleotide), exhibits antitumor activity. However, ara-T and xylo-T did not exhibit cytotoxicity. Compared to tiazofurin, only 12.5% of the ara-T and 8.8% of the xylo-T were metabolized to TAD derivatives by human myelogenous leukemia K562 cells. This was reflected in the finding that guanylate pools were not depressed after treatment with either tiazofurin derivative. These results provide evidence that the ribose moiety is essential for the metabolism and cytotoxicity of tiazofurin. This investigation should be helpful in the design of new analogues of tiazofurin for future clinical trials.

AB - 2-β-D-Arabinofuranosylthiazole-4-carboxamide and 2-β-D-xylofuranosyl-thiazole-4-carboxamide are sugar modified analogues of tiazofurin, a C-glycosyl nucleoside which after anabolism to the dinucleotide, TAD (thiazole-4-carboxamide adenine dinucleotide), exhibits antitumor activity. However, ara-T and xylo-T did not exhibit cytotoxicity. Compared to tiazofurin, only 12.5% of the ara-T and 8.8% of the xylo-T were metabolized to TAD derivatives by human myelogenous leukemia K562 cells. This was reflected in the finding that guanylate pools were not depressed after treatment with either tiazofurin derivative. These results provide evidence that the ribose moiety is essential for the metabolism and cytotoxicity of tiazofurin. This investigation should be helpful in the design of new analogues of tiazofurin for future clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0025824718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025824718&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(05)81155-6

DO - 10.1016/S0006-291X(05)81155-6

M3 - Article

C2 - 1683233

AN - SCOPUS:0025824718

VL - 180

SP - 933

EP - 938

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -